The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on disposal of property and equipment | - | - | - | 0 |
| Non-cash lease (gain) expense | - | 489 | - | - |
| Change in fair value of warrant liabilities | - | -840 | - | 53 |
| Net loss | -7,329 | -10,515 | -11,058 | -28,609 |
| Depreciation | 183 | 291 | 352 | 782 |
| Gain on sale of equipment | 133 | -1,915 | - | - |
| Stock-based compensation | 1,064 | 1,103 | 2,049 | 4,983 |
| Non-cash lease expense | -610 | - | 253 | 485 |
| Change in fair value of warrant liabilities | - | - | -234 | - |
| Change in accrued interest and net accretion of discounts on short-term investments | -6 | 10 | -2 | 180 |
| Prepaid expenses and other current assets | -320 | 131 | -443 | -497 |
| Accounts payable | 136 | -10 | 275 | -537 |
| Accrued expenses | -286 | 151 | -2,163 | -2,215 |
| Right-of-use assets | - | 5,285 | - | - |
| Lease liabilities | -441 | -5,621 | -312 | -587 |
| Other current liabilities | -21 | - | - | - |
| Other noncurrent assets | -6 | -10 | 18 | -28 |
| Net cash used in operating activities | -6,325 | -9,312 | -10,464 | -25,300 |
| Purchases of property and equipment | 9 | 127 | - | 5 |
| Sales (purchases) of property and equipment | - | - | 122 | - |
| Proceeds from sale of equipment | 133 | - | - | - |
| Purchases of available-for-sale investments | 1,216 | 6,378 | 3,948 | 11,014 |
| Proceeds from sales and maturities of available-for-sale investments | 6,152 | 9,411 | 13,757 | 30,451 |
| Net cash provided by investing activities | 5,060 | 3,023 | 9,692 | 19,432 |
| Proceeds from issuance of class a common stock and pre-funded warrants in connection with registered direct offering | - | 5,865 | - | - |
| Issuance costs related to issuance of class a common stock and pre-funded warrants in connection with registered direct offering | - | 696 | - | - |
| Proceeds from note payable | - | 576 | - | - |
| Repayments on note payable | 154 | 51 | - | - |
| Proceeds from exercise of stock options | - | 0 | 26 | 41 |
| Net cash (used in) provided by financing activities | -154 | 5,694 | 26 | 41 |
| Change in cash, cash equivalents and restricted cash | -1,419 | -595 | -746 | -5,827 |
| Cash, cash equivalents and restricted cash, beginning of period | 3,505 | 4,100 | 10,673 | - |
| Cash, cash equivalents and restricted cash, end of period | 2,086 | 3,505 | 4,100 | - |
Vicarious Surgical Inc. (RBOT)
Vicarious Surgical Inc. (RBOT)